Levy Wealth Management Group’s Bristol-Myers Squibb BMY Stock Holding History

Levy Wealth Management Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-8,021	Closed	-$466K	–	105
2023 Q3	$466K	Buy	8,021 +62	+0.8%	+$3.8K	0.14%	61
2023 Q2	$509K	Buy	7,959 +58	+0.7%	+$3.89K	0.15%	54
2023 Q1	$548K	Buy	7,901 +53	+0.7%	+$3.74K	0.17%	51
2022 Q4	$565K	Sell	7,848 -45	-0.6%	-$3.39K	0.19%	49
2022 Q3	$561K	Buy	7,893 +6	+0.1%	+$435	0.24%	39
2022 Q2	$607K	Buy	7,887 +182	+2%	+$13.9K	0.28%	35
2022 Q1	$563K	Buy	7,705 +55	+0.7%	+$3.69K	0.23%	37
2021 Q4	$477K	Buy	7,650 +54	+0.7%	+$3.17K	0.22%	41
2021 Q3	$449K	Buy	7,596 +47	+0.6%	+$3.1K	0.25%	39
2021 Q2	$504K	Buy	7,549 +3,149	+72%	+$205K	0.29%	36
2021 Q1	$278K	Buy	+4,400	New	+$274K	0.18%	48

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Levy Wealth Management Group's BMY Position: Q4 2023 in Review

Levy Wealth Management Group sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 8,021 shares — an estimated $466K sold.

Levy Wealth Management Group first reported a position in BMY in Q1 2021 and held it in 11 quarters. The position peaked at $607K in Q2 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Levy Wealth Management Group reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Levy Wealth Management Group sold 8,021 Bristol-Myers Squibb shares in Q4 2023, an estimated $466K.
Levy Wealth Management Group first reported a position in Bristol-Myers Squibb in Q1 2021 and held it in 11 quarters.
Levy Wealth Management Group's Bristol-Myers Squibb position peaked at $607K in Q2 2022.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Levy Wealth Management Group's 13F filing for Q4 2023, filed 23 Jan 2024.